438 related articles for article (PubMed ID: 27516139)
1. Tegaderm™ CHG dressing significantly improves catheter-related infection rate in hemodialysis patients.
Righetti M; Palmieri N; Bracchi O; Prencipe M; Bruschetta E; Colombo F; Brenna I; Stefani F; Amar K; Scalia A; Conte F
J Vasc Access; 2016 Sep; 17(5):417-422. PubMed ID: 27516139
[TBL] [Abstract][Full Text] [Related]
2. Chlorhexidine-impregnated transparent dressings decrease catheter-related infections in hemodialysis patients: a quality improvement project.
Apata IW; Hanfelt J; Bailey JL; Niyyar VD
J Vasc Access; 2017 Mar; 18(2):103-108. PubMed ID: 28165583
[TBL] [Abstract][Full Text] [Related]
3. Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised controlled trial.
Chan RJ; Northfield S; Larsen E; Mihala G; Ullman A; Hancock P; Marsh N; Gavin N; Wyld D; Allworth A; Russell E; Choudhury MA; Flynn J; Rickard CM
Trials; 2017 Oct; 18(1):458. PubMed ID: 28978332
[TBL] [Abstract][Full Text] [Related]
4. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
Winnicki W; Herkner H; Lorenz M; Handisurya A; Kikić Ž; Bielesz B; Schairer B; Reiter T; Eskandary F; Sunder-Plassmann G; Sengoelge G
Kidney Int; 2018 Mar; 93(3):753-760. PubMed ID: 28890326
[TBL] [Abstract][Full Text] [Related]
5. [The Incidences of Catheter Colonization and Central Line-Associated Bloodstream Infection According to Tegaderm vs. Chlorhexidine Gluconate (CHG)-Tegaderm Dressing].
Kim E; Lee H
J Korean Acad Nurs; 2020 Aug; 50(4):541-553. PubMed ID: 32895341
[TBL] [Abstract][Full Text] [Related]
6. Reducing bloodstream infection with a chlorhexidine gel IV dressing.
Jeanes A; Bitmead J
Br J Nurs; 2015 Oct 22-Nov 11; 24(19):S14-9. PubMed ID: 26496869
[TBL] [Abstract][Full Text] [Related]
7. Economic impact of use of chlorhexidine-impregnated sponge dressing for prevention of central line-associated infections in the United States.
Ye X; Rupnow M; Bastide P; Lafuma A; Ovington L; Jarvis WR
Am J Infect Control; 2011 Oct; 39(8):647-654. PubMed ID: 21641681
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of chlorhexidine patches on central line-associated bloodstream infections in children.
Jitrungruengnij N; Anugulruengkitt S; Rattananupong T; Prinyawat M; Jantarabenjakul W; Wacharachaisurapol N; Chatsuwan T; Janewongwirot P; Suchartlikitwong P; Tawan M; Kanchanabutr P; Pancharoen C; Puthanakit T
Pediatr Int; 2020 Jul; 62(7):789-796. PubMed ID: 32065485
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study.
Schwebel C; Lucet JC; Vesin A; Arrault X; Calvino-Gunther S; Bouadma L; Timsit JF
Crit Care Med; 2012 Jan; 40(1):11-7. PubMed ID: 21926570
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of a chlorhexidine intravascular catheter gel dressing on short-term central venous catheters.
Karpanen TJ; Casey AL; Whitehouse T; Nightingale P; Das I; Elliott TS
Am J Infect Control; 2016 Jan; 44(1):54-60. PubMed ID: 26455868
[TBL] [Abstract][Full Text] [Related]
11. Peripherally InSerted CEntral catheter dressing and securement in patients with cancer: the PISCES trial. Protocol for a 2x2 factorial, superiority randomised controlled trial.
Rickard CM; Marsh NM; Webster J; Gavin NC; Chan RJ; McCarthy AL; Mollee P; Ullman AJ; Kleidon T; Chopra V; Zhang L; McGrail MR; Larsen E; Choudhury MA; Keogh S; Alexandrou E; McMillan DJ; Mervin MC; Paterson DL; Cooke M; Ray-Barruel G; Castillo MI; Hallahan A; Corley A; Geoffrey Playford E
BMJ Open; 2017 Jun; 7(6):e015291. PubMed ID: 28619777
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness Analysis of a Transparent Antimicrobial Dressing for Managing Central Venous and Arterial Catheters in Intensive Care Units.
Maunoury F; Motrunich A; Palka-Santini M; Bernatchez SF; Ruckly S; Timsit JF
PLoS One; 2015; 10(6):e0130439. PubMed ID: 26086783
[TBL] [Abstract][Full Text] [Related]
13. Comparison of chlorhexidine impregnated dressing and standard dressing for the prevention of central-line associated blood stream infection and colonization in critically ill pediatric patients: A randomized controlled trial.
Duyu M; Karakaya Z; Yazici P; Yavuz S; Yersel NM; Tascilar MO; Firat N; Bozkurt O; Caglar Mocan Y
Pediatr Int; 2022 Jan; 64(1):e15011. PubMed ID: 34610185
[TBL] [Abstract][Full Text] [Related]
14. A comparative evaluation of antimicrobial coated versus nonantimicrobial coated peripherally inserted central catheters on associated outcomes: A randomized controlled trial.
Storey S; Brown J; Foley A; Newkirk E; Powers J; Barger J; Paige K
Am J Infect Control; 2016 Jun; 44(6):636-41. PubMed ID: 27240799
[TBL] [Abstract][Full Text] [Related]
15. Targeting zero catheter-related bloodstream infections in pediatric intensive care unit: a retrospective matched case-control study.
Biasucci DG; Pittiruti M; Taddei A; Picconi E; Pizza A; Celentano D; Piastra M; Scoppettuolo G; Conti G
J Vasc Access; 2018 Mar; 19(2):119-124. PubMed ID: 29148002
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial on healthy volunteers of pharmacokinetic and antimicrobial activity of a novel hydrogel-containing chlorhexidine dressing to prevent catheter-related bloodstream infection.
Masferrer E; Riera-Rodríguez L; Farré-Alins V; Vilà de Muga S; Arroyo-Muñoz FJ; González-Caro MD
Front Med (Lausanne); 2023; 10():1335364. PubMed ID: 38259833
[TBL] [Abstract][Full Text] [Related]
17. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.
Maki DG; Stolz SM; Wheeler S; Mermel LA
Ann Intern Med; 1997 Aug; 127(4):257-66. PubMed ID: 9265424
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial and cost-effectiveness analysis of early cannulation arteriovenous grafts versus tunneled central venous catheters in patients requiring urgent vascular access for hemodialysis.
Aitken E; Thomson P; Bainbridge L; Kasthuri R; Mohr B; Kingsmore D
J Vasc Surg; 2017 Mar; 65(3):766-774. PubMed ID: 28236919
[TBL] [Abstract][Full Text] [Related]
19. Is 2% chlorhexidine gluconate in 70% isopropyl alcohol more effective at preventing central venous catheter-related infections than routinely used chlorhexidine gluconate solutions: A pilot multicenter randomized trial (ISRCTN2657745)?
McCann M; Fitzpatrick F; Mellotte G; Clarke M
Am J Infect Control; 2016 Aug; 44(8):948-9. PubMed ID: 27079247
[TBL] [Abstract][Full Text] [Related]
20. Cost-benefit analysis of chlorhexidine gluconate dressing in the prevention of catheter-related bloodstream infections.
Crawford AG; Fuhr JP; Rao B
Infect Control Hosp Epidemiol; 2004 Aug; 25(8):668-74. PubMed ID: 15357159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
